Allred Commends Eli Lilly and Novo Nordisk for Responding to Congressional Pressure and Reducing Insulin Costs
March 15, 2023
March 15, 2023
DALLAS, Texas, March 15 -- Rep. Colin Allred, D-Texas, issued the following news release on March 14, 2023:
Congressman Colin Allred (TX-32) today applauded Novo Nordisk for joining Eli Lilly in announcing that they would cap the out-of-pocket costs for their insulins following Congressional action to cap insulin costs at $35 per month for folks on Medicare. Allred has been fighting to protect access to affordable health care since his first day in Congress and helped lead the charg . . .
Congressman Colin Allred (TX-32) today applauded Novo Nordisk for joining Eli Lilly in announcing that they would cap the out-of-pocket costs for their insulins following Congressional action to cap insulin costs at $35 per month for folks on Medicare. Allred has been fighting to protect access to affordable health care since his first day in Congress and helped lead the charg . . .